|
US7219016B2
(en)
|
2001-04-20 |
2007-05-15 |
Yale University |
Systems and methods for automated analysis of cells and tissues
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
AU2002311919B8
(en)
|
2001-05-11 |
2007-03-22 |
Ludwig Institute For Cancer Research Ltd |
Specific binding proteins and uses thereof
|
|
ES2425749T3
(es)
|
2004-03-31 |
2013-10-17 |
The General Hospital Corporation |
Método para determinar la respuesta del cáncer a tratamientos dirigidos al receptor del factor de crecimiento epidérmico
|
|
EP3042964A1
(en)
|
2004-06-04 |
2016-07-13 |
Genentech, Inc. |
Egfr mutations
|
|
TW200617396A
(en)
*
|
2004-10-06 |
2006-06-01 |
Astrazeneca Ab |
Method
|
|
RU2460804C2
(ru)
*
|
2004-10-18 |
2012-09-10 |
Брандейс Юнивесити |
Способ гомогенной детекции по меньшей мере одного продукта одноцепочечной амплификации
|
|
JPWO2006070667A1
(ja)
*
|
2004-12-28 |
2008-06-12 |
タカラバイオ株式会社 |
Ｅｇｆｒ遺伝子変異の検出法ならびに検出キット
|
|
KR101313702B1
(ko)
|
2005-02-03 |
2013-10-04 |
와이어쓰 |
제피티니브 및/또는 에를로티니브 내성암 치료용 약제학적 조성물
|
|
EP2505591A1
(en)
|
2005-02-11 |
2012-10-03 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for detecting a drug resistant EGFR mutant
|
|
MX2007009963A
(es)
|
2005-02-24 |
2007-09-26 |
Amgen Inc |
Mutaciones del receptor del factor de crecimiento epidermico.
|
|
GB0506670D0
(en)
*
|
2005-04-01 |
2005-05-11 |
Astrazeneca Ab |
Method
|
|
GB2424886A
(en)
*
|
2005-04-04 |
2006-10-11 |
Dxs Ltd |
Polynucleotide primers against epidermal growth factor receptor and method of detecting gene mutations
|
|
EP1874920A4
(en)
|
2005-04-05 |
2009-11-04 |
Cellpoint Diagnostics |
DEVICES AND METHOD FOR ENRICHING AND CHANGING CIRCULATING TUMOR CELLS AND OTHER PARTICLES
|
|
CA2646257A1
(en)
*
|
2005-04-14 |
2006-10-26 |
Wyeth |
Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients
|
|
CA2612183C
(en)
*
|
2005-06-28 |
2015-08-11 |
Genentech, Inc. |
Egfr and kras mutations
|
|
WO2007039705A1
(en)
*
|
2005-10-05 |
2007-04-12 |
Astrazeneca Uk Limited |
Method to predict or monitor the response of a patient to an erbb receptor drug
|
|
EP1942937A1
(en)
|
2005-11-04 |
2008-07-16 |
Wyeth |
Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272
|
|
JP5688877B2
(ja)
|
2005-11-11 |
2015-03-25 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
癌疾患の治療用キナゾリン誘導体
|
|
PT1948180E
(pt)
*
|
2005-11-11 |
2013-05-10 |
Boehringer Ingelheim Int |
Tratamento de combinação de cancro compreendendo inibidores de egfr/her2
|
|
JPWO2007099852A1
(ja)
*
|
2006-02-23 |
2009-07-16 |
国立大学法人金沢大学 |
固形癌のチロシンキナーゼ阻害剤に対する感受性を検査する方法及び検査キット
|
|
US7867775B2
(en)
*
|
2006-03-31 |
2011-01-11 |
Biodesix, Inc. |
Selection of head and neck cancer patients for treatment with drugs targeting EGFR pathway
|
|
US7906342B2
(en)
|
2006-03-31 |
2011-03-15 |
Biodesix, Inc. |
Monitoring treatment of cancer patients with drugs targeting EGFR pathway using mass spectrometry of patient samples
|
|
US7736905B2
(en)
|
2006-03-31 |
2010-06-15 |
Biodesix, Inc. |
Method and system for determining whether a drug will be effective on a patient with a disease
|
|
US8367351B2
(en)
|
2006-05-05 |
2013-02-05 |
Historx, Inc. |
Methods for determining signal transduction activity in tumors
|
|
US8768629B2
(en)
*
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
US12366585B2
(en)
|
2006-05-18 |
2025-07-22 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
CN103424541B
(zh)
*
|
2006-05-18 |
2018-01-30 |
分子压型学会股份有限公司 |
确定针对病状的个性化医疗介入的系统和方法
|
|
WO2007147079A2
(en)
|
2006-06-14 |
2007-12-21 |
Living Microsystems, Inc. |
Rare cell analysis using sample splitting and dna tags
|
|
EP2589668A1
(en)
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Rare cell analysis using sample splitting and DNA tags
|
|
JP2009544007A
(ja)
*
|
2006-07-13 |
2009-12-10 |
イェール・ユニバーシティー |
バイオマーカーの細胞内局在性に基づいて癌予後を行う方法
|
|
AU2007299080B2
(en)
*
|
2006-09-18 |
2013-04-18 |
Boehringer Ingelheim International Gmbh |
Method for treating cancer harboring EGFR mutations
|
|
US8283625B2
(en)
*
|
2006-09-28 |
2012-10-09 |
Shimadzu Corporation |
Method of preparing sample for matrix-assisted laser desorption ionization mass spectrometry and matrix-assisted laser desorption ionization mass spectrometry
|
|
JP4795203B2
(ja)
*
|
2006-11-13 |
2011-10-19 |
シスメックス株式会社 |
アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム
|
|
US9090693B2
(en)
|
2007-01-25 |
2015-07-28 |
Dana-Farber Cancer Institute |
Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease
|
|
KR101598229B1
(ko)
|
2007-02-16 |
2016-02-26 |
메리맥 파마슈티컬즈, 인크. |
Ｅｒｂｂ3에 대한 항체 및 이의 용도
|
|
PT2412828E
(pt)
*
|
2007-03-13 |
2013-08-02 |
Amgen Inc |
Mutações k-ras e b-raf e terapia com anticorpos anti-egfr
|
|
RS53265B2
(sr)
|
2007-03-13 |
2022-06-30 |
Amgen Inc |
K-ras mutacije i terapija anti-egfr antitelom
|
|
CA2680854C
(en)
|
2007-03-15 |
2017-02-14 |
Ludwig Institute For Cancer Research |
Treatment method using egfr antibodies and src inhibitors and related formulations
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US8999634B2
(en)
|
2007-04-27 |
2015-04-07 |
Quest Diagnostics Investments Incorporated |
Nucleic acid detection combining amplification with fragmentation
|
|
CA2686908A1
(en)
|
2007-05-11 |
2008-11-20 |
Enzon Pharmaceuticals, Inc. |
Rna antagonist compounds for the modulation of her3
|
|
US20090155767A1
(en)
*
|
2007-06-29 |
2009-06-18 |
Rimm David L |
Methods for a predictive diagnostic test for tamoxifen
|
|
CN108424454B
(zh)
|
2007-08-14 |
2022-05-31 |
路德维格癌症研究所有限公司 |
靶向egf受体的单克隆抗体175及其衍生物和用途
|
|
US8022216B2
(en)
|
2007-10-17 |
2011-09-20 |
Wyeth Llc |
Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof
|
|
KR101810799B1
(ko)
|
2008-02-01 |
2017-12-19 |
더 제너럴 하스피탈 코포레이션 |
의학적 질환 및 병태의 진단, 예후, 및 치료에 있어서 미세소포체의 용도
|
|
PT2271767T
(pt)
*
|
2008-04-03 |
2016-08-18 |
Cb Biotechnologies Inc |
Reação em cadeia de polimerase para captura de amplicões em multiplexo para amplificação de alvos múltiplos
|
|
US8137919B2
(en)
*
|
2008-04-10 |
2012-03-20 |
Montefiore Medical Center |
Method of determining the sensitivity of cancer cells to EGFR inhibitors including cetuximab, panitumumab and erlotinib
|
|
CN101445829B
(zh)
*
|
2008-04-23 |
2013-06-05 |
广州益善生物技术有限公司 |
Egfr基因突变位点的检测探针、液相芯片及其检测方法
|
|
BRPI0914790A2
(pt)
|
2008-06-17 |
2015-10-20 |
Wyeth Llc |
uso de um composto de vinorelbina e um composto de hki-272, composição farmacêutica e produto e kit para o tratamento de neoplasma
|
|
US8669273B2
(en)
|
2008-08-04 |
2014-03-11 |
Wyeth Llc |
Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
|
|
WO2010019952A2
(en)
*
|
2008-08-15 |
2010-02-18 |
Merrimack Pharmaceuticals, Inc. |
Methods, systems and products for predicting response of tumor cells to a therapeutic agent and treating a patient according to the predicted response
|
|
WO2010028288A2
(en)
|
2008-09-05 |
2010-03-11 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
|
US8633015B2
(en)
|
2008-09-23 |
2014-01-21 |
Bio-Rad Laboratories, Inc. |
Flow-based thermocycling system with thermoelectric cooler
|
|
US12090480B2
(en)
|
2008-09-23 |
2024-09-17 |
Bio-Rad Laboratories, Inc. |
Partition-based method of analysis
|
|
US9399215B2
(en)
|
2012-04-13 |
2016-07-26 |
Bio-Rad Laboratories, Inc. |
Sample holder with a well having a wicking promoter
|
|
EP4512526A3
(en)
|
2008-09-23 |
2025-06-04 |
Bio-Rad Laboratories, Inc. |
Droplet-based assay system
|
|
US9417190B2
(en)
|
2008-09-23 |
2016-08-16 |
Bio-Rad Laboratories, Inc. |
Calibrations and controls for droplet-based assays
|
|
US12162008B2
(en)
|
2008-09-23 |
2024-12-10 |
Bio-Rad Laboratories, Inc. |
Partition-based method of analysis
|
|
US9156010B2
(en)
|
2008-09-23 |
2015-10-13 |
Bio-Rad Laboratories, Inc. |
Droplet-based assay system
|
|
US11130128B2
(en)
|
2008-09-23 |
2021-09-28 |
Bio-Rad Laboratories, Inc. |
Detection method for a target nucleic acid
|
|
US8709762B2
(en)
|
2010-03-02 |
2014-04-29 |
Bio-Rad Laboratories, Inc. |
System for hot-start amplification via a multiple emulsion
|
|
US8663920B2
(en)
|
2011-07-29 |
2014-03-04 |
Bio-Rad Laboratories, Inc. |
Library characterization by digital assay
|
|
WO2011120020A1
(en)
|
2010-03-25 |
2011-09-29 |
Quantalife, Inc. |
Droplet transport system for detection
|
|
US8951939B2
(en)
|
2011-07-12 |
2015-02-10 |
Bio-Rad Laboratories, Inc. |
Digital assays with multiplexed detection of two or more targets in the same optical channel
|
|
US10512910B2
(en)
|
2008-09-23 |
2019-12-24 |
Bio-Rad Laboratories, Inc. |
Droplet-based analysis method
|
|
US9132394B2
(en)
|
2008-09-23 |
2015-09-15 |
Bio-Rad Laboratories, Inc. |
System for detection of spaced droplets
|
|
US9764322B2
(en)
|
2008-09-23 |
2017-09-19 |
Bio-Rad Laboratories, Inc. |
System for generating droplets with pressure monitoring
|
|
US9492797B2
(en)
|
2008-09-23 |
2016-11-15 |
Bio-Rad Laboratories, Inc. |
System for detection of spaced droplets
|
|
WO2010045318A2
(en)
*
|
2008-10-14 |
2010-04-22 |
Caris Mpi, Inc. |
Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
|
|
EP3722810A3
(en)
*
|
2009-02-11 |
2021-01-13 |
Caris MPI, Inc. |
Molecular profiling of tumors
|
|
WO2010101916A1
(en)
*
|
2009-03-02 |
2010-09-10 |
Trackfive Diagnostics Inc |
Methods for predicting cancer response to egfr inhibitors
|
|
DK3000467T3
(da)
|
2009-04-06 |
2023-03-27 |
Wyeth Llc |
Behandling med neratinib mod brystkræft
|
|
PT2451445T
(pt)
|
2009-07-06 |
2019-07-10 |
Boehringer Ingelheim Int |
Processo para secagem de bibw2992, dos seus sais e de formulações farmacêuticas sólidas compreendendo este ingrediente ativo
|
|
CA2767056C
(en)
|
2009-09-02 |
2018-12-04 |
Bio-Rad Laboratories, Inc. |
System for mixing fluids by coalescence of multiple emulsions
|
|
US20130029339A1
(en)
|
2009-09-09 |
2013-01-31 |
The General Hospital Corporation |
Use of microvesicles in analyzing kras mutations
|
|
WO2011031982A1
(en)
*
|
2009-09-10 |
2011-03-17 |
Myriad Genetics, Inc. |
Methods and compositions for predicting cancer therapy response
|
|
US7947653B1
(en)
|
2009-10-09 |
2011-05-24 |
Cold Spring Harbor Laboratory |
Methods for treating epidermal growth factor receptor tyrosine kinase inhibitor-resistant cancers
|
|
US8323883B1
(en)
|
2009-10-09 |
2012-12-04 |
Cold Spring Harbor Laboratory |
Methods of assessing therapeutic benefits of patients having cancers resistant to epidermal growth factor receptor kinase inhibitors
|
|
CA2780332C
(en)
|
2009-11-09 |
2018-01-30 |
Wyeth Llc |
Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea
|
|
CA2780875A1
(en)
|
2009-11-13 |
2011-05-19 |
Pangaea Biotech, S.L. |
Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
|
|
US9034658B2
(en)
|
2009-11-23 |
2015-05-19 |
The General Hospital Corporation |
Microfluidic devices for the capture of biological sample components
|
|
US10731221B2
(en)
|
2009-12-11 |
2020-08-04 |
Dignity Health |
Diagnosing IDH1 related subgroups and treatment of cancer
|
|
US20120252856A1
(en)
*
|
2009-12-11 |
2012-10-04 |
Dignity Health |
Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy
|
|
TWI405566B
(zh)
*
|
2010-02-11 |
2013-08-21 |
Univ Nat Taiwan |
薑黃素或其類似物於使用上皮細胞生長因子接受器酪胺酸激酶抑制劑之癌症醫療之用途
|
|
US8399198B2
(en)
|
2010-03-02 |
2013-03-19 |
Bio-Rad Laboratories, Inc. |
Assays with droplets transformed into capsules
|
|
KR101798679B1
(ko)
|
2010-03-11 |
2017-11-16 |
메리맥 파마슈티컬즈, 인크. |
３중 음성 및 기저형 유방암 치료 시의 ｅｒｂｂ３ 저해제의 용도
|
|
JP2013522613A
(ja)
*
|
2010-03-18 |
2013-06-13 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
化学療法に対する応答性を予測するための方法
|
|
JP2013524169A
(ja)
|
2010-03-25 |
2013-06-17 |
クァンタライフ・インコーポレーテッド |
液滴によるアッセイ用の検出システム
|
|
CA2767182C
(en)
|
2010-03-25 |
2020-03-24 |
Bio-Rad Laboratories, Inc. |
Droplet generation for droplet-based assays
|
|
CN102234683B
(zh)
*
|
2010-04-23 |
2013-07-17 |
广州益善生物技术有限公司 |
一种egfr基因突变检测液相芯片
|
|
CN101858909B
(zh)
*
|
2010-05-28 |
2013-07-03 |
广州瑞博奥生物科技有限公司 |
检测磷酸化表皮生长因子受体的试剂盒及其制备方法
|
|
EP2619329B1
(en)
|
2010-09-24 |
2019-05-22 |
The Board of Trustees of The Leland Stanford Junior University |
Direct capture, amplification and sequencing of target dna using immobilized primers
|
|
CN103080314B
(zh)
*
|
2010-09-30 |
2016-04-13 |
Lsip基金运营联合公司 |
显性突变基因表达抑制剂
|
|
EA201390575A1
(ru)
|
2010-10-29 |
2014-01-30 |
Иммьюноджен, Инк. |
Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты
|
|
EA201390472A1
(ru)
|
2010-10-29 |
2014-02-28 |
Иммьюноджен, Инк. |
Новые молекулы, связывающиеся с egfr, и их иммуноконъюгаты
|
|
EP3574990B1
(en)
|
2010-11-01 |
2022-04-06 |
Bio-Rad Laboratories, Inc. |
System for forming emulsions
|
|
WO2012065071A2
(en)
*
|
2010-11-12 |
2012-05-18 |
The Broad Institute Of Mit And Harvard |
Methods of predicting response to egfr antibody therapy
|
|
WO2012065705A1
(en)
|
2010-11-19 |
2012-05-24 |
Roche Diagnostics Gmbh |
Novel complex mutation in the epidermal growth factor receptor kinase domain
|
|
US20120164641A1
(en)
|
2010-12-22 |
2012-06-28 |
Roche Molecular Systems, Inc. |
Methods and Compositions for Detecting Mutation in the Human Epidermal Growth Factor Receptor Gene
|
|
CN102140518B
(zh)
*
|
2011-01-18 |
2013-02-06 |
杭州迪安医学检验中心有限公司 |
肺癌相关表皮生长因子受体egfr外显子突变定量检测试剂盒及方法
|
|
US8914238B2
(en)
|
2011-01-28 |
2014-12-16 |
Biodesix, Inc. |
Method for predicting breast cancer patient response to endocrine therapy
|
|
US9738930B2
(en)
|
2011-01-28 |
2017-08-22 |
The Broad Institute, Inc. |
Paired end bead amplification and high throughput sequencing
|
|
CN103649331A
(zh)
|
2011-02-15 |
2014-03-19 |
莱卡生物系统纽卡斯尔有限责任公司 |
用于mrna的定位的原位检测的方法
|
|
US9556473B2
(en)
|
2011-02-15 |
2017-01-31 |
Leica Biosystems Newcastle Ltd |
Methods for identifying nucleic acid sequences
|
|
US12097495B2
(en)
|
2011-02-18 |
2024-09-24 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for detecting genetic material
|
|
EP2492688A1
(en)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molecular biomarkers for predicting response to antitumor treatment in lung cancer
|
|
CN103534360A
(zh)
|
2011-03-18 |
2014-01-22 |
伯乐生命医学产品有限公司 |
借助对信号的组合使用进行的多重数字分析
|
|
WO2012129145A1
(en)
|
2011-03-18 |
2012-09-27 |
OSI Pharmaceuticals, LLC |
Nscle combination therapy
|
|
EP3395957B1
(en)
|
2011-04-25 |
2020-08-12 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for nucleic acid analysis
|
|
JP5930825B2
(ja)
*
|
2011-05-06 |
2016-06-08 |
アークレイ株式会社 |
Ｅｇｆｒエクソン１９多型検出試験用試薬キット及びその用途
|
|
US9404864B2
(en)
|
2013-03-13 |
2016-08-02 |
Denovo Sciences, Inc. |
System for imaging captured cells
|
|
US9174216B2
(en)
|
2013-03-13 |
2015-11-03 |
DeNovo Science, Inc. |
System for capturing and analyzing cells
|
|
CN103998394B
(zh)
|
2011-08-01 |
2016-08-17 |
德诺弗科学公司 |
细胞捕获系统和使用方法
|
|
US10466160B2
(en)
|
2011-08-01 |
2019-11-05 |
Celsee Diagnostics, Inc. |
System and method for retrieving and analyzing particles
|
|
US10364464B2
(en)
|
2011-08-08 |
2019-07-30 |
The Broad Institute, Inc. |
Compositions and methods for co-amplifying subsequences of a nucleic acid fragment sequence
|
|
US9738935B2
(en)
*
|
2011-11-10 |
2017-08-22 |
Roche Molecular Systems, Inc. |
Complex mutations in the epidermal growth factor receptor kinase domain
|
|
CA2856411A1
(en)
|
2011-11-21 |
2013-05-30 |
Immunogen, Inc. |
Method of treatment of tumors that are resistant to egfr therapies by egfr antibody cytotoxic agent conjugate
|
|
US9260714B2
(en)
|
2011-12-02 |
2016-02-16 |
Roche Molecular Systems, Inc. |
Suppression of non-specific amplification with high-homology oligonucleotides
|
|
KR101963230B1
(ko)
|
2011-12-26 |
2019-03-29 |
삼성전자주식회사 |
복수개의 단일 항체를 포함하는 단백질 복합체
|
|
EP2653558B1
(en)
|
2012-04-18 |
2015-10-07 |
Roche Diagniostics GmbH |
A method of detecting nucleic acid targets using a statistical classifier
|
|
CN102732636B
(zh)
*
|
2012-07-17 |
2014-01-15 |
海南医学院 |
一种检测肿瘤细胞egfr基因突变的芯片
|
|
CN102851375B
(zh)
*
|
2012-09-11 |
2014-02-19 |
上海源奇生物医药科技有限公司 |
检测egfr基因突变的引物、探针及其试剂盒和使用方法
|
|
KR101911438B1
(ko)
*
|
2012-10-31 |
2018-10-24 |
삼성전자주식회사 |
이중 특이 항원 결합 단백질 복합체 및 이중 특이 항체의 제조 방법
|
|
US20140341884A1
(en)
*
|
2012-12-04 |
2014-11-20 |
Roche Molecular Systems, Inc. |
Novel Complex Mutations in the Epidermal Growth Factor Receptor Kinase Domain
|
|
US9752181B2
(en)
|
2013-01-26 |
2017-09-05 |
Denovo Sciences, Inc. |
System and method for capturing and analyzing cells
|
|
EP2964638B1
(en)
|
2013-03-06 |
2017-08-09 |
Astrazeneca AB |
Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor
|
|
ES2662598T3
(es)
|
2013-03-08 |
2018-04-09 |
F. Hoffmann-La Roche Ag |
Análisis de sangre para la detección de mutaciones de EGFR
|
|
US20140287417A1
(en)
|
2013-03-08 |
2014-09-25 |
Roche Molecular Systems, Inc. |
EGFR Blood Monitoring
|
|
US9707562B2
(en)
|
2013-03-13 |
2017-07-18 |
Denovo Sciences, Inc. |
System for capturing and analyzing cells
|
|
US10391490B2
(en)
|
2013-05-31 |
2019-08-27 |
Celsee Diagnostics, Inc. |
System and method for isolating and analyzing cells
|
|
US9856535B2
(en)
|
2013-05-31 |
2018-01-02 |
Denovo Sciences, Inc. |
System for isolating cells
|
|
CN103333963A
(zh)
*
|
2013-06-09 |
2013-10-02 |
中国人民解放军第四军医大学 |
Egfr突变检测引物组及其用途
|
|
WO2014203918A1
(ja)
*
|
2013-06-19 |
2014-12-24 |
学校法人 久留米大学 |
上皮成長因子受容体チロシンキナーゼ阻害薬の治療効果を予測する方法
|
|
US9783504B2
(en)
|
2013-07-09 |
2017-10-10 |
Dana-Farber Cancer Institute, Inc. |
Kinase inhibitors for the treatment of disease
|
|
EP3087394A2
(en)
|
2013-12-27 |
2016-11-02 |
Merrimack Pharmaceuticals, Inc. |
Biomarker profiles for predicting outcomes of cancer therapy with erbb3 inhibitors and/or chemotherapies
|
|
US9242965B2
(en)
|
2013-12-31 |
2016-01-26 |
Boehringer Ingelheim International Gmbh |
Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
|
|
CN103923975B
(zh)
*
|
2014-01-27 |
2016-01-20 |
上海涌泰生物医药科技有限公司 |
一种检测egfr基因外显子19缺失突变的试剂盒和方法
|
|
WO2015178946A1
(en)
|
2014-04-04 |
2015-11-26 |
Biodesix, Inc. |
Treatment selection for lung cancer patients using mass spectrum of blood-based sample
|
|
CN106573967B
(zh)
*
|
2014-07-28 |
2022-02-18 |
玛尔医学研究所基金会 |
表皮生长因子受体基因的胞外域iii中的突变
|
|
EP3204510B1
(en)
|
2014-10-09 |
2018-07-25 |
Roche Diagnostics GmbH |
Mutations in the epidermal growth factor receptor kinase domain
|
|
KR101692044B1
(ko)
*
|
2014-12-05 |
2017-01-04 |
사회복지법인 삼성생명공익재단 |
교모세포종에서 표피 성장인자 수용체 억제제의 치료 효과를 예측하는 방법
|
|
US12595297B2
(en)
*
|
2015-05-12 |
2026-04-07 |
In3Bio Ltd. |
Methods and compositions for inhibition of EGF/EGFR pathway in combination with tyrosine kinase inhibitors
|
|
US10184006B2
(en)
|
2015-06-04 |
2019-01-22 |
Merrimack Pharmaceuticals, Inc. |
Biomarkers for predicting outcomes of cancer therapy with ErbB3 inhibitors
|
|
US10273281B2
(en)
|
2015-11-02 |
2019-04-30 |
Five Prime Therapeutics, Inc. |
CD80 extracellular domain polypeptides and their use in cancer treatment
|
|
WO2017139694A1
(en)
*
|
2016-02-12 |
2017-08-17 |
Nantomics, Llc |
High-throughput identification of patient-specific neoepitopes as therapeutic targets for cancer immunotherapies
|
|
CN105624309B
(zh)
*
|
2016-02-23 |
2020-04-21 |
深圳华大生命科学研究院 |
检测EGFR和/或K-ras基因突变的引物、探针及试剂盒
|
|
CN105866217B
(zh)
*
|
2016-03-21 |
2018-04-10 |
杭州市红十字会医院 |
三尖杉酯碱癌症治疗效果检测装置及方法
|
|
KR102449693B1
(ko)
*
|
2016-05-25 |
2022-09-30 |
주식회사 젠큐릭스 |
상피세포 성장인자 수용체 유전자 돌연변이 검출용 조성물 및 이를 포함하는 키트
|
|
EP3612210A4
(en)
|
2017-04-19 |
2021-01-27 |
Board Of Regents, The University Of Texas System |
MANIPULATED ANTIGEN RECEPTORS EXPRESSING IMMUNE CELLS
|
|
WO2018201584A1
(zh)
*
|
2017-05-03 |
2018-11-08 |
华为技术有限公司 |
基于竞争的传输方法和设备
|
|
US10299039B2
(en)
|
2017-06-02 |
2019-05-21 |
Apple Inc. |
Audio adaptation to room
|
|
US10391492B2
(en)
|
2017-08-29 |
2019-08-27 |
Celsee Diagnostics, Inc. |
System and method for isolating and analyzing cells
|
|
WO2019074920A1
(en)
*
|
2017-10-10 |
2019-04-18 |
Oncocyte Corporation |
METHODS AND COMPOSITIONS FOR THE DETECTION AND DIAGNOSIS OF BREAST CANCER
|
|
CN109722476A
(zh)
*
|
2017-10-31 |
2019-05-07 |
北京雅康博生物科技有限公司 |
用于检测egfr基因2237-2257位突变的引物、探针及试剂盒
|
|
US12473336B2
(en)
|
2018-02-21 |
2025-11-18 |
Board Of Regents, The University Of Texas System |
Methods for activation and expansion of natural killer cells and uses thereof
|
|
WO2019213195A1
(en)
*
|
2018-05-01 |
2019-11-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
T cell receptors which recognize mutated egfr
|
|
WO2020080871A2
(ko)
*
|
2018-10-18 |
2020-04-23 |
(주)신테카바이오 |
암 약물 반응성 판단을 위한 바이오 마커 조성물, 바이오 마커 조성물을 이용한 암 약물 반응성 판단 방법 및 암 약물 반응성 판단을 위한 바이오 마커 조성물 검출용 진단칩
|
|
BR112021016149A2
(pt)
|
2019-02-26 |
2021-10-13 |
Janssen Biotech, Inc. |
Terapias de combinação e estratificação de pacientes com anticorpos biespecíficos anti-egfr/c-met
|
|
US10633693B1
(en)
|
2019-04-16 |
2020-04-28 |
Celsee Diagnostics, Inc. |
System and method for leakage control in a particle capture system
|
|
AU2020267743B2
(en)
|
2019-05-07 |
2023-04-06 |
Bio-Rad Laboratories, Inc. |
System and method for automated single cell processing
|
|
US11273439B2
(en)
|
2019-05-07 |
2022-03-15 |
Bio-Rad Laboratories, Inc. |
System and method for target material retrieval from microwells
|
|
US11879013B2
(en)
|
2019-05-14 |
2024-01-23 |
Janssen Biotech, Inc. |
Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors
|
|
US11850248B2
(en)
|
2019-05-14 |
2023-12-26 |
Yuhan Corporation |
Therapies with 3rd generation EGFR tyrosine kinase inhibitors
|
|
WO2020251802A1
(en)
|
2019-06-14 |
2020-12-17 |
Bio-Rad Laboratories, Inc. |
System and method for automated single cell processing and analyses
|
|
GB2627085B
(en)
|
2019-11-06 |
2024-11-13 |
Univ Leland Stanford Junior |
Methods and systems for analysing nucleic acid molecules
|
|
JP7783182B2
(ja)
|
2020-02-12 |
2025-12-09 |
ヤンセン バイオテツク，インコーポレーテツド |
ｃ－ＭＥＴエクソン１４スキッピング変異を有する患者の治療
|
|
US11475981B2
(en)
|
2020-02-18 |
2022-10-18 |
Tempus Labs, Inc. |
Methods and systems for dynamic variant thresholding in a liquid biopsy assay
|
|
US11211147B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
|
|
US11211144B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Methods and systems for refining copy number variation in a liquid biopsy assay
|
|
CN111154881A
(zh)
*
|
2020-03-09 |
2020-05-15 |
南京实践医学检验有限公司 |
一种急性髓系白血病中基因突变的检测试剂盒及应用
|
|
US11504719B2
(en)
|
2020-03-12 |
2022-11-22 |
Bio-Rad Laboratories, Inc. |
System and method for receiving and delivering a fluid for sample processing
|
|
US20220025453A1
(en)
*
|
2020-07-23 |
2022-01-27 |
Michael Y Sha |
Xenonucleic acid-mediated multiplex qpcr clamping technology for lung cancer mutation detection
|
|
CN114107449B
(zh)
*
|
2020-08-31 |
2024-04-09 |
中山大学孙逸仙纪念医院 |
一种单细胞内原位qPCR方法
|
|
CN111996193B
(zh)
*
|
2020-09-11 |
2024-02-20 |
北京键凯科技股份有限公司 |
一种有效抑制表皮生长因子受体表达的siRNA序列
|
|
US11783912B2
(en)
|
2021-05-05 |
2023-10-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and systems for analyzing nucleic acid molecules
|
|
CN113564255A
(zh)
*
|
2021-08-13 |
2021-10-29 |
河北医科大学第四医院 |
一种lncRNA NEAT1_1的应用
|
|
DE102021126650A1
(de)
|
2021-10-14 |
2023-04-20 |
Rheinische Friedrich-Wilhelms-Universität Bonn, Körperschaft des öffentlichen Rechts |
Verfahren zur bestimmung der ansprechwahrscheinlichkeit einer malignen erkrankung auf eine behandlung mit einem pharmazeutischen hemmwirkstoff
|
|
CN118369438A
(zh)
|
2021-12-10 |
2024-07-19 |
伯乐实验室有限公司 |
用形态可调节功能化颗粒进行样品处理的组合物、方法和系统
|
|
CN114113265B
(zh)
*
|
2021-12-14 |
2023-08-08 |
郑州轻工业大学 |
一种适配体传感器及其制备方法
|
|
CA3246851A1
(en)
*
|
2022-03-31 |
2025-02-03 |
National Cancer Center |
SOLID CANCER TREATMENT BIOMARKER BY IMIDAZO[4,5-B]PYRIDINE DERIVATIVE
|
|
TW202515577A
(zh)
*
|
2023-06-27 |
2025-04-16 |
日商大鵬藥品工業股份有限公司 |
患有具有ｅｇｆｒ畸變的非小細胞肺癌之個體的治療方法
|
|
KR20250011598A
(ko)
*
|
2023-07-14 |
2025-01-21 |
전남대학교산학협력단 |
암 진단을 위한 시료 처리 방법 및 이를 이용한 암 진단에 대한 정보 제공 방법
|
|
CN117778322B
(zh)
*
|
2023-12-17 |
2025-02-07 |
苏州拓维生物技术有限公司 |
一种对恩杂鲁胺耐药的细胞系的筛选方法及其应用
|